A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT01456689 · COMPLETED
Trial details
- NCT number
- NCT01456689
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-25
- Primary completion
- 2019-06-05
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.